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Abstract 
The dihydropyranyl segment common to ambruticin and jerangolid A was prepared in six steps (31.7% yield) 
from (S)-2-benzyloxypropanal via silyloxydiene cyclocondensation, followed by C-glycosidation, and eventual 
epimerization at C18. 
Graphical abstract 




Hetero-Diels–Alder cycloaddition, C-glycosidation 
Ambruticin (1, Scheme 1) is a structurally unique carboxylic acid isolated from Polyangium cellulosum var. 
fulvum, which exhibits potent oral antifungal activity against Coccidioides immitis, Histoplasma 
capsulatum and Blastomyces dermititidis.1 Extensive spectral analysis revealed that the structure of 1 consists of 
a tetrahydropyranyl ring, a dihydropyranyl ring and a divinylcyclopropane ring. More recently, the jerangolids A 
and D (2a,b), isolated from a strain of Sorangium cellulosum (So ce 307), were found to exhibit antifungal activity 
similar to that of 1.2 The structure of 2 from C6–C18 is identical with the C13–C24 segment of ambruticin, and 
similar antibiotic spectrum of 1 and 2 suggests that these segments are responsible for their biological activity. 
The complex array of diverse functionality present in 1 has generated considerable synthetic interest,3 including 
total syntheses by the groups of Kende et al.,4 Martin and co-workers,5 Lee et al.6 and Liu and Jacobsen.7 To our 
knowledge, there are no reported syntheses of the jerangolids. As part of our interest in the preparation of C-
glycosides,8 we herein report the enantioselective preparation of the common dihydropyranyl segment 3, an 
intermediate in the Martin synthesis of 1.5 
 
Scheme 1. 
Construction and elaboration of the oxane ring was envisioned by means of a Lewis acid catalyzed diene–
aldehyde cyclocondensation reaction,9 followed by a C-glycosidation of the derived pseudoglycal. Since C-
glycosidation generally proceeds via axial attack on an oxonium ion to afford trans-2,6-disubstituted pyrans, it 
was anticipated that a subsequent epimerization at C18 (ambruticin numbering) would be necessary to generate 
the desired cis-18,22 relative stereochemistry. To this end, reaction of 2(S)-benzyloxypropanal (4)10 with 1-
methoxy-2-methyl-3-(trimethylsiloxy)-1,3-butadiene (5)11 in the presence of BF3-etherate, followed by work-up 
with TFA gave an inseparable mixture of diastereomeric dihydropyrones 6 and 7 (Scheme 2). The relative 
stereochemistry of 6 and 7 was assigned on the basis of their 1H NMR spectral data.12 In particular, the signals 
for H17 and H19eq (ambruticin numbering) of 6 (δ 3.69 and 2.36 ppm, respectively), appear upfield of the 
corresponding signals for 7 (δ 3.81 and 2.56 ppm, respectively). These relative chemical shifts are quite 
characteristic of diastereomeric dihydropyrones with an α-alkoxy group.13 Cyclocondensation of 4 with 5 in the 
presence of MgBr2, followed by work-up with TFA gave only dihydropyrone (+)-6. The S configuration at C18 
(ambruticin numbering) of 6 is the result of approach of the diene in an exo sense on the less hindered face of 
the Mg2+ chelated form of optically active aldehyde 4. 
 
Scheme 2. 
Reduction of 6 gave the pseudoglycal (+)-8 as a single diastereomer (Scheme 3). We8a and others14 have 
reported that the reaction of glycals with trialkylaluminium reagents is useful for the preparation of C-alkyl 
glycosides. To this end, treatment of pseudoglycal 8 with the weak nucleophile triethylaluminium, in the 
presence of boron trifluoride etherate, gave a mixture of trans- and cis-dihydropyrans (8:1 ratio). The major 
product arises via axial attack of the weak nucleophile on the cyclic oxonium ion generated by ionization of 8. 
The pure trans-isomer, (−)-9, was obtained in good yield after column chromatography. Removal of the benzyl 
protecting group, followed by oxidation gave (−)-11.15 Base-catalyzed epimerization of the trans-ketone, in 
benzene, gave a separable mixture of (−)-11 and (+)-3 (1:2 ratio).16 Two equilibration/separation cycles gave 




In summary, the synthesis of the dihydropyranyl segment (3), common to ambruticin and the jerangolids, from 
optically active aldehyde 4, was accomplished in six steps (31.7% overall yield). The length and yield of our 
synthetic route is competitive with that reported by Martin and co-workers.5 
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